Desai J, Gan H, Barrow C, Jameson MB, Mcarthur G

[1] Desai J, Gan H, Barrow C, Jameson MB, Mcarthur G, Tran B, Lam M, et al. Phase I study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors. Presentation Session: Clinical Trials Plenary Session, Sunday, April 17, 4:15-6 p.m. CT, La Nouvelle Orleans Ballroom. AACR 2016 Abstract: CT007.